Autoantibodies Associated with Diabetes Mellitus in Nigerian Subjects Resident in Port-Harcourt Metropolis
Asian Journal of Research and Reports in Endocrinology,
Aim: The aim of this study was to determine the autoantibodies associated with diabetes mellitus among diabetics in Port- Harcourt of Rivers State, Nigeria
Study Design: This study is a cross-sectional study.
Place and Duration of Study: This study was conducted at Chemical Pathology Department, Rivers State University Teaching Hospital, Port Harcourt, Nigeria, between December, 2019 and February, 2020.
Methodology: A total of 244 subjects, both male and females, 132 subjects 112 controls, aged within 30-70 years. Five (5) ml of blood sample for Islet cell cytoplasm autoantibodies (ICA), Glutamic acid decarboxylase autoantibodies (GADA), Insulinoma-associated-2 autoantibodies (1A-2A) and zinc transporter 8 autoantibodies (ZnT8A), were collected serum obtained was analyzed using Enzyme-linked immunoasorbent assay. Data were analyzed statistically with SPSS version 22.0 and value considered significant at p≤ 0.05.
Results: The mean ± S.D of serum ICA were 4.48± 2.18u/ml (control) and 14.91±11.11 u/ml (subject), GADA value were 0.99 ± 0.22u/ml(control) and 1.78 ±0.77u/ml (subjects), IA-2A values were 3.83±1.56 u/ml (control) and 4.20±3.26u/ml and ZnT8A values were 5.61±4.29u/ml (control) and 6.02±3.80u/ml (subjects). The comparison of mean showed significant difference at p=0.0001 for ICA but no significant differences observed GADA, IA-2A and ZnT8A at p=0.152, p=0.595 and p=0.686 respectively.
Conclusion: Diabetes mellitus patient with positive ICA, GADA and IA-2A autoantibodies, higher HbA1c and lower C-peptide suggest an autoimmune or intracellular damage of beta-cells in T2DM and need for insulin dependence or progression to LADA.
- diabetes mellitus
- Port Harcourt metropolis
How to Cite
Ake L. A population-based analysis of autoantibodies was performed in Swedish children newly diagnosed, Autoantibodies, 2016; 2(1): 22-4.
Pierre P, Alessandra KC, Decio LE, Sae P. Mediator and Mechanisms of pancreatic beta-cell death in type 1 Diabetes. Bosn J of Basic Med Sci, 2017;17(3):120-30.
Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in Diabetes. Diabetes, 2005;54(2):52-61.
Allewa D, Whilly M, Nivetha M. Prevalence of diabetes mellitus. Diabetes Care, 2018; 1:1-3.
RSR Diagnostics for Autoimmunity. Determination of Serum 3-screen Cell Cytoplasmic Autoantibodies (ICA) by Immunoassay. RSR Limited, Parc Ty Glas Llanishen Cardiff CF14 5DU U.K; 2002.
Nathan DM, Singer DE, Hurxthal K, Goodson JD. The Clinical Information Value of the Glycosylated Hemoglobin Assay. New Engl. J. Med. 1984;310:341-6.
Wisdom GB. Enzyme-Immunassay. Clinical Chemistry, 1976;22:1243-5.
Shu-ling, F. Review performed in clinical chemistry Department pathology. Boston Medical Center, Bosn Journal of Basic Medical Science, 2017;17(4): 90-100.
Trabucchi A, Faccinetti NI, Guerra LL. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity. 2012;45(2): 137-42 .
Lu ZH, Liu N, Bai R. HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation. Herz, 2015;40:130–36.
Mourad, HL. Hypoglycaemia in Clinical Biochemistry: Metabolic and Clinical Aspects, 2014;3:333-48.
Andrew JM, Boulton, Rayaz AM. Endocrinology: Adult and Pediatric (Seventh Edition). 2016;920-33.
Elias S, Siraj1, Carol H, Laura AW, Patrick, N Ajay DR, Jorge C, Gianrico F., William, L.H, Kenneth, LK, Linda N, Williams AS, Thomas AS, Irene S, Richard WM, Pankaj JP, John C, James T., Frank H, Henry PP. Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis. Frontier Endocrinology, 2018;9:32-5.
Ahmad, G, Reza S. Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus. World Journal Diabetes, 2015;6(1):145-50.
Jurgita Janukonyté J, Parkner T, Bruun, NH, Lauritzen T, Christiansen JS. Laursen T. Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patients. Epub, 2015;17(5):335-42.
Li X, Xu X, Liu J. HbA1c and survival in maintenance hemodialysis patients with diabetes in Han Chinese population. International Urology Nephrology. 2014; 46: 2207–14.
Rumei, L., Jinya H., Yifei Y, Yehong Y. Islet Autoantibody Patterns in Patients With Type 2 Diabetes Aged 60 and Higher: A Cross-Sectional Study in a Chinese Hospital. Front Endocrinology (Lausanne), 2018;9:260-3.
Romesh K. Type 1 Diabetes Mellitus. Medscape, 2019;4: 24-7.
Sujesh, KN, Subhakumari KN. Role of anti-GAD, anti-IA2 antibodies and C-peptide in differentiating latent autoimmune diabetes in adults from type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries, 2016;36(3):313– 9.
Marina DS, Selma M, Jasenko K, Djemo S, Tomislav J, Jozo C, Ognjen R, Mirsad P, Lejla Z. ELISA Test for analysing of incidence of Type 1 Diabetes autoantibodies (GAD and IA2) in children and Adolescents. American Association of Diabetes. 2016;24(1):61- 65.
Frederic W, Michael RC. Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane–Associated Antigen in (Pre)type 1 Diabetes Association with IA-2 and islet cell autoantibodies, Diabetes Care. 2015;24(7):1181-6.
Abstract View: 122 times
PDF Download: 60 times